Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose esketamine for suicidality
RBR-5df3vz9Phase 2Recruiting
- Sponsor
- Universidade Federal de Santa Maria
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in suicidal ideation comparing Esketamine with Midazolam active placebo (2 arms). Started Jun 2020; status: recruiting.
02
Drugs
esketamine
03
Conditions
suicidal ideation
Beyond the preview
Go deeper on RBR-5df3vz9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5df3vz9.